Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.731
-0.099 (-3.51%)
Jul 2, 2026, 9:10 AM EDT - Market open
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,894,632
Market Cap
21.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | -9 | -45.00% |
| Dec 31, 2023 | 20 | 5 | 33.33% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Quince Therapeutics | 38 |
| Palatin Technologies | 29 |
| Lipocine | 14 |
| NewcelX | 12 |
| VYNE Therapeutics | 10 |
| Allarity Therapeutics | 8 |
| AEON Biopharma | 8 |
CLRB News
- 4 weeks ago - Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 4 weeks ago - Cellectar Biosciences Slides: Corporate presentation - Filings
- 4 weeks ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 5 weeks ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings
- 5 weeks ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings
- 6 weeks ago - Cellectar Biosciences files to sell 51.21M shares of common stock for holders - TheFly
- 6 weeks ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 6 weeks ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings